Serum test identifies patients deriving benefit from CPIs 197 5 Supplementary Figure S3: Heatmap for the samples in the development cohort of the 29 mass spectral features (associated with Immune Response type 2) used for classifier C.
RkJQdWJsaXNoZXIy MTk4NDMw